The Primary
Care Companionfor CNS Disorders

Depression (MDD)

Article June 1, 2004

The Benefits of Exercise for the Clinically Depressed

Lynette L. Craft, PhD; Frank M. Perna, EdD, PhD

Prim Care Companion J Clin Psychiatry 2004;6(3):104-111

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

The Benefits of Exercise for the Clinically Depressed.

View Related Activity

Go to Activity

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Article

Brain Zaps

December 20, 2018

Brain zaps are a poorly understood symptom of antidepressant discontinuation, which require further study for both better prevention and treatment. This article describes the characteristics of brain zaps and...

Alexander Papp, Julie A. Onton

Article

ECT in Obsessive-Compulsive-Related Disorders

October 18, 2018

Obsessive-compulsive-related disorders include conditions such as body dysmorphic disorder and skin-picking disorder, as well as tic disorders and self-injurious behaviors. Could electroconvulsive therapy be an effective treatment option? Read...

Samara dos Santos-Ribeiro, Juliana B. de Salles Andrade, Julliana N. Quintas, et al

Article

Glabellar Botulinum for Depression

October 4, 2018

Glabellar injection of botulinum toxin A (BTA) provides a novel and interesting strategy to address shortcomings in the treatment of depression. This study examines the primary clinical trials conducted...

Toren P. Stearns, Mujeeb U. Shad, Gabriela C. Guzman

The Benefits of Exercise for the Clinically Depressed

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

The Benefits of Exercise for the Clinically Depressed

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Brain Zaps

ECT in Obsessive-Compulsive-Related Disorders

Glabellar Botulinum for Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles